Vijaya Diagnostic Centre raises Rs566.12cr from anchor investors ahead of the IPO
The price band for the public issue has been fixed at Rs522-531.
Vijaya Diagnostic has finalized 29 anchor investors, allotting 10,661,418 shares at Rs531 per share aggregating Rs566.12cr.
The list includes high-quality long-only investors such as Fidelity Management Research, Fidelity Investments, Aberdeen, Abu Dhabi Investment Authority (ADIA), Kuwait Investment Authority (KIA), Government Pension Fund Global.
The anchor saw participation from all large blue-chip domestic mutual funds, including SBI Mutual Fund, Axis Mutual Fund, Aditya Birla Mutual Fund, ICICI Prudential Mutual Fund, Nippon India Mutual Fund, Franklin Templeton Mutual Fund, Mirae Mutual Fund and DSP Mutual Fund.
Other large institutions that participated include Kotak India Growth Fund, Goldman Sachs, Pioneer Investment Fund, CLSA, ICICI Prudential Life, SBI Life Insurance, Kotak Life Insurance, Bajaj Allianz Life etc.
The price band for the public issue has been fixed at Rs522-531.
Recent companies based out of Hyderabad that went public include Gland Pharma and KIMS Hospital. While Gland Pharma is up 160% since IPO in November last year, KIMS Hospital is up 55% since IPO in June this year.
The list includes high-quality long-only investors such as Fidelity Management Research, Fidelity Investments, Aberdeen, Abu Dhabi Investment Authority (ADIA), Kuwait Investment Authority (KIA), Government Pension Fund Global.
The anchor saw participation from all large blue-chip domestic mutual funds, including SBI Mutual Fund, Axis Mutual Fund, Aditya Birla Mutual Fund, ICICI Prudential Mutual Fund, Nippon India Mutual Fund, Franklin Templeton Mutual Fund, Mirae Mutual Fund and DSP Mutual Fund.
Other large institutions that participated include Kotak India Growth Fund, Goldman Sachs, Pioneer Investment Fund, CLSA, ICICI Prudential Life, SBI Life Insurance, Kotak Life Insurance, Bajaj Allianz Life etc.
The price band for the public issue has been fixed at Rs522-531.
Recent companies based out of Hyderabad that went public include Gland Pharma and KIMS Hospital. While Gland Pharma is up 160% since IPO in November last year, KIMS Hospital is up 55% since IPO in June this year.
Topic Participants
Basavaraj Hiremath
Sticky Posts
10 things to know about the Sansera Engineering Limited IPO
The Company derives 64.98% of total revenue from sale of products from India and 35.02% of total revenue from the sale of products from Europe, the USA and other foreign countries combined. Below are the 10 things to know about the Sansera EngineeringAmi Organics raises Rs170.89cr from 20 anchor investors at the upper price band of Rs610 per equity share
Bid can be made for a minimum of 24 Equity Shares and in multiples of 24 Equity Shares thereafter. Ami Organics Limited has allocated 28,01,485 equity shares to 20 anchor investors and raised Rs170.89cr ahead of the company’s proposed IPO at the upperVijaya Diagnostic Centre raises Rs566.12cr from anchor investors ahead of the IPO
The price band for the public issue has been fixed at Rs522-531. Vijaya Diagnostic has finalized 29 anchor investors, allotting 10,661,418 shares at Rs531 per share aggregating Rs566.12cr. The list includes high-quality long-only investors such as FidelityTop things to know - AMI Organics Limited IPO
As per the F&S Report, the company is one of the major manufacturers of Pharma Intermediates for certain key APIs, including Dolutegravir, Trazodone, Entacapone, Nintedanib and Rivaroxaban. Here is a top thing to know about AMI Organics Limited IPO: 1.Top things to know - Vijaya Diagnostic Center Limited IPO
The issue will have a price band of Rs522 to Rs531 per equity share of the face value of Re. 1 each (“Equity Shares”). Here is a top thing to know about Vijaya Diagnostic Center Limited IPO: 1) The Issue: The Initial Public Offering comprises of an offer